INS and type 1 diabetes mellitus: First, it was the first crossover, randomized control trial of metformin add-on treatment in lean/normal-weight adolescents with T1D with comprehensive assessments including metabolic parameters, insulin sensitivity, glucose variability as assessed by CGM, and change in cardiovascular autonomic function as assessed by HRV derived from 24-hour Holter monitoring.